The SURPASS-2 trial, which compared the two drugs in patients with type 2 diabetes, found that all three tirzepatide doses were superior to semaglutide in reducing HbA1c levels
Subscribers gain access to digital tools for tracking progress, hydration, sleep, and physical activity
Medical Disclaimer: The content provided in this newsletter is for informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
The $499 tirzepatide refill buried in the FAQ is also accurate
57,69,78,94,296 The ONATA study showed a negative correlation between serum uric acid levels and insulin sensitivity, suggesting a potential link between uric acid, insulin sensitivity, and the risk of developing hypertension